Bonnie H Anderson Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 2 hours ago
Bonnie H Anderson has an estimated net worth of at least $16.5 million*, as of Dec. 11, 2024. They own 153,803 shares of VCYT stock. They have sold 371,664 shares of VCYT stock since 2021, for an estimated $9.9 million.
Bonnie H Anderson $VCYT SEC Form 4 Insider Trading
Bonnie H Anderson has filed a total of 12 insider trades in $VCYT since 2021. Their most recent trade was a sale of 34,000 shares, made on Apr 14, 2023. Their largest trade was a sale of 76,917 shares, made on Aug 05, 2022. We estimate that they now own 153,803 shares of $VCYT, worth an estimated $6.7 million.
Insider Trading at $VCYT
There have been a total of 94 insider trades reported at $VCYT since 2021, with 62,000 shares purchased and 786,335 shares sold. The most active insider traders in $VCYT stock have been Giulia C Kennedy, Bonnie H Anderson, and John Leite. The most recent trade was a sale of 3,934 shares reported by Phillip G. Febbo (Chief Scientific & Med Officer), made on Dec 04, 2024.
History of Insider Stock Trades by Bonnie H Anderson
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
VCYT | Sale | 34,000 | Apr 14, 2023 | April 18, 2023, 4:44 p.m. |
VCYT | Sale | 34,000 | Mar 15, 2023 | March 16, 2023, 4:54 p.m. |
VCYT | Sale | 29,506 | Jan 17, 2023 | Jan. 18, 2023, 6:08 p.m. |
VCYT | Sale | 4,494 | Jan 17, 2023 | Jan. 18, 2023, 6:08 p.m. |
VCYT | Sale | 63,247 | Jan 11, 2023 | Jan. 12, 2023, 6:27 p.m. |
VCYT | Sale | 45,460 | Dec 01, 2022 | Dec. 5, 2022, 5:56 p.m. |
VCYT | Sale | 34,540 | Dec 01, 2022 | Dec. 5, 2022, 5:56 p.m. |
VCYT | Sale | 76,917 | Aug 05, 2022 | Aug. 9, 2022, 1:16 p.m. |
VCYT | Sale | 39,231 | Aug 08, 2022 | Aug. 9, 2022, 1:16 p.m. |
VCYT | Sale | 5,769 | Aug 08, 2022 | Aug. 9, 2022, 1:16 p.m. |
VCYT | Sale | 2,600 | Sep 17, 2021 | Sept. 20, 2021, 8 p.m. |
VCYT | Sale | 1,900 | Sep 10, 2021 | Sept. 13, 2021, 8 p.m. |
$VCYT Executives and Stock Owners with Insider Trades
-
Giulia C Kennedy, Chief Scientific & Med Officer
-
Bonnie H Anderson, Executive Chairwoman
-
John Leite, Chief Commercial Officer-CLIA
-
Jonathan Wygant, VP, Chief Accounting Officer
-
Rebecca Chambers, Chief Financial Officer
-
Annie Mcguire, SVP, General Counsel
-
Marc Stapley, Chief Executive Officer
-
Phillip G. Febbo, Chief Scientific & Med Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.